Granules India Limited, a leading vertically integrated pharmaceutical company, announced its financial results for the fourth quarter (Q4) and full fiscal year (FY) 2024, ending March 31, 2024. The report paints a mixed picture, with a slight decline in overall revenue balanced by a significant increase in the North American market. Revenue Trends and Market …